The planning, coordination, and administration of translational studies are undertaken by a team of project managers under the leadership of Ruth Witt in collaboration with the Trial Development Group. The spectrum of studies ranges from molecular diagnostic registries to Phase III clinical trials, with a focus on sponsor-specific tasks for Phase I/II IITs. All our studies are conducted within international/transatlantic networks. Therefore, the Study Management Group focuses particularly on managing various regulatory requirements and active networking. Additionally, the group is involved in resolving regulatory and administrative barriers at national and European levels.
